Atlas Trials

A Study of Brexpiprazole in Patients With Major Depressive Disorder

Clinical trial NCT03697603 · COMPLETED

Trial details

NCT number
NCT03697603
Sponsor
Otsuka Pharmaceutical Co., Ltd.
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Major Depressive Disorder
Start date
2018-07-30
Primary completion
2022-06-06
Enrollment
740

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.